Publications Development of low-molecular-weight compounds targeting the cancer-associated KLF5 transcription factor October 26, 2023 By vera ← PreviousPRISM BioLab announces a milestone achievement based on the license agreement with Ohara PharmaceuticalNext →Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein–Protein Interaction between CTLA-4 and B7-1
English 
Japanese 
